To end the year I’d like to share our last work, comments are welcome! www.biorxiv.org/content/10.6...

Just kicked off the #BarcelonaBioMed Conference “When Development Meets #Cancer-Origins, Models & Therapies in #ChildhoodCancer” Excited to hear from an outstanding line-up of speakers! Organized by #IRBBarcelona & @sjdhospitalbarcelona.org With the support of Fundación @bbvaenespana.bsky.social

Indeed!

Very proud on our stellar Alina Ritter for her frist first-author paper: Targeting CXADR-mediated AKT signaling suppresses tumorigenesis and enhances #chemotherapy efficacy in #Ewing #sarcoma tinyurl.com/3kcs3bc9 @dkfz.bsky.social @uniheidelberg.bsky.social @nct-heidelberg.bsky.social

We’re happy 😄 to share our latest work in Cancer Discov @theaacr.bsky.social – we discover that PTEN UPD 🧬 in endothelial cells causes vascular malformations in PTEN Hamartoma Tumor Syndrome (PHTS), create a new mouse model 🐀 & test PI3K signaling inhibitors 💊. aacrjournals.org/cancerdiscov...

Targeting replication stress in neuroblastoma by exploiting the synergistic potential of second generation RRM2 and CHK1 inhibitors www.biorxiv.org/content/10.1...

In #biotech #stocks news, Donald Trump’s return to the White House is already having a big impact at the $47.4 billion U.S. National Institutes of Health (NIH), with the new administration imposing a wide range of restrictions, including the abrupt cancellation of grant review panels.

doi.org/10.1002/1878... Happy to share our last work! Great effort by @marionachicon.bsky.social and great collaborations! #ewingsarcoma #metastasis #animalmodels #research

December is always a good month! We have new doctor in da house! #sarcoma #research Sara Sánchez-Serra 👏🏻👏🏻👏🏻 Very proud of her!

I'm really happy to post for the first time here the words written in an incoming e-mail I just got: Dear Dr. Martinez Tirado: We are delighted to inform you that your manuscript....😃 #sarcoma #metastasis #mousemodel